Synthesis and characterization of new ferrocenyl compounds with different alkyl chain lengths and functional groups to target breast cancer cells

Journal of Organometallic Chemistry

Volumn 751, Issue , 2014, Pages 610-619

  De Cázares Marinero, José Jesús ^a   Top, Siden ^a   Jaouen, Gérard ^a  

^a PSL RESEARCH UNIVERSITY   (France)

Author keywords

Anticancer activity; Ferrocene; MCF 7; Medicinal chemistry; Organometallics; Triple negative breast cancer cells

Indexed keywords

CHAIN LENGTH; CYTOLOGY; CYTOTOXICITY; DISEASES; ENZYME INHIBITION; ORGANOMETALLICS;

ANTICANCER ACTIVITIES; FERROCENES; MCF-7; MEDICINAL CHEMISTRY; TRIPLE-NEGATIVE BREAST CANCERS;

CELLS;

EID: 84893718980     PISSN: 0022328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jorganchem.2013.07.031     Document Type: Article

References (21)

1. G Jaouen, Bioorganometallics, John Wiley & Sons, Germany, 2006.
2. E.A Hillard, G Jaouen, Bioorganometallics: future trends in drug discovery, analytical chemistry and catalysis, Organometallics 30 (2011) 20-27.
3. J.J. Cázares-Marinero, M Lapierre, V. Cavaillès, R Saint-Fort, A. Vessières, S Top, G Jaouen, Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species, Dalton Trans. (2013), http://dx.doi.org/10.1039/C3DT51917A.
4. P.A Marks, R. Breslow, Nat. Biotechnol. 25 (2007) 84-90.
5. B.S Mann, J.R Johnson, M.H. Cohen, R Justice, R Pazdur, Oncologist 12 (2007) 1249-1252.
6. S Top, A. Vessières, G Leclercq, J. Quivy, J Tang, J. Vaissermann, M Huché, G Jaouen, Chem Eur J. 9 (2003) 5223-5236.
7. J Spencer, J Amin, M. Wang, G Packman, S.S Syed Alwi, G.J Tizzard, S.J. Coles, ACS Med. Chem Lett. 2 (2011) 358-362.
8. D. Can, H.W Peindy N'Dongo, B Spingler, P Schmutz, P Raposinho, I Santos, R Alberto, Chem. Biodiversity 9 (2012) 1849-1866.
9. D.M Griffith, B Szöcs, T. Keogh, K.Y Suponitsky, E. Farkas, P. Buglyó, C.J Marmion, J. Inorg. Biochem. 105 (2011) 763-769.
10. D Griffith, J.P Parker, C.J Marmion, Anticancer Agents Med. Chem. 10 (2010) 354-370.
11. M Librizzi, A Longo, R. Chiarelli, J Amin, J Spencer, C Luparello, Chem Res Toxicol. 25 (2012) 2608-2616.
12. L Jin, N Legros, G Leclercq, I.R Hardcastle, M Jarman, Cancer Chemother Pharmacol. 41 (1998) 339-342.
13. M.A Lea, A Shareef, M Sura, C. desBordes, Chemother Pharmacol. 54 (2004) 57-63.
14. S Hanessian, L Auzzas, G Giannini, M Marzi, W. Cabri, M. Barbarino, L. Vesci, C Pisano, Bioorg Med. Chem Lett. 17 (2007) 6261-6265.
15. J.L Tischler, B Abuaita, S.C. Cuthpert, C. Fage, K Murphy, A Saxe, E.B. Furr, J Hedrick, J Meyers, D Snare, A.R. Zand, J Enzyme Inhib Med. Chem. 23 (2008) 549-555.
16. X. Cai, H.X. Zhai, J. Wang, J. Forrester, H. Qu, L. Yin, C.J Lai, R. Bao, C. Qian, J Med. Chem. 53 (2010) 2000-2009.
17. M. Zuo, Y.W. Zeng, S.M Lu, Y Li, S.Q. Zhang, Bioorg Med. Chem. 20 (2012) 4405-4412.
18. A. Nguyen, S Top, P Pigeon, A. Vessières, E.A Hillard, M.A Plamont, M Huché, C Rigamonti, G Jaouen, Chem Eur J. 15 (2009) 684-696.
19. P Pigeon, S Top, O. Zekri, E.A Hillard, A. Vessières, M.A Plamont, O. Buriez, E Labbé, M Huché, S. Boutamine, C Amatore, G Jaouen, J. Organomet. Chem. 694 (2009) 895-901.
20. J.J. Cázares-Marinero, O. Buriez, E Labbé, S Top, C Amatore, G Jaouen, Synthesis, characterization and antiproliferative activities of novel ferrocenophanic suberamides against human triple-negative MDA-MB-231 and hormone-dependent MCF-7 breast cancer cells, in press.
21. A.K Shiau, D. Barstad, P.M Loria, L. Cheng, P.J. Kushner, D.A Agard, G Greene, Cell 95 (1998) 927-937.